Page last updated: 2024-10-23

bisacodyl and Obesity

bisacodyl has been researched along with Obesity in 1 studies

Bisacodyl: A diphenylmethane stimulant laxative used for the treatment of CONSTIPATION and for bowel evacuation. (From Martindale, The Extra Pharmacopoeia, 30th ed, p871)

Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lingvay, I1
Sumithran, P1
le Roux, CW1
Cohen, RV1

Other Studies

1 other study available for bisacodyl and Obesity

ArticleYear
There is no magic bullet for obesity.
    The lancet. Diabetes & endocrinology, 2023, Volume: 11, Issue:8

    Topics: Bisacodyl; Humans; Obesity

2023